Navigation Links
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
Date:10/17/2007

s or likelihood of success of our product research and development programs; the status of our preclinical and clinical development of potential drugs; the likelihood of success of our drug products in clinical trials and the regulatory approval process; our drug products' efficacy, abuse and tamper resistance, onset and duration of drug action, ability to provide protection from overdose, ability to reduce the development of tolerance, ability to improve symptomatology or otherwise improve patients' symptoms; the incidence of adverse events; the ability to develop, manufacture, launch and market our drug products; our projections for future revenues, profitability and ability to achieve certain sales targets; our estimates regarding our capital requirements and our needs for additional financing; the likelihood of obtaining favorable scheduling and labeling of our drug products; the likelihood of regulatory approval under Section 505(b)(2) and other applicable Sections under the Federal Food, Drug, and Cosmetic Act; our ability to develop safer and improved versions of widely- prescribed drugs using our technology; and our ability to obtain favorable patent claims. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Cutanea Life Sciences does not undertake any obligation to republish revised forward- looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact:

The Ruth Group

Sara Ephraim (investors)

646-536-7002

sephraim@theruthgroup.com

Jason Rando (media)

646-536-7025

jrando@theruthgroup.com

Cutanea Life Sciences

Kimberley Forbes-McKean, Ph.D.

484-568-0106

KFMcKean@CutaneaLife.com


'/>"/>
SOURCE Cutanea Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Medical Science Liaisons serve as ... in the healthcare sector. As the impact of technology ... changing how Medical Science Liaisons (MSLs) interact with physicians ... using the tablet to not only share important disease ... coordinate thought leader interactions across geographies and therapeutic areas. ...
(Date:8/22/2014)... 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... instrument for any modern science laboratory as ... materials. It can be broadly classified into ...
(Date:8/22/2014)... DUBLIN , August 22, 2014 /PRNewswire/ ... ) has announced the addition of the  ... to their offering.       (Logo: ... room with a sterile environment in a ... It is equipped with technically advanced equipment, ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... The U.S. Food and Drug Administration approved on June 13 ... with osteoarthritis. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... shape of a ball at the top of the ... the pelvis (acetabulum).  During total hip replacement surgery, worn ...
... SAN MARINO, Calif., June 14, 2011 Viral ... transition to a clinical-stage company. The Company,s two ... various Metabolic Disruption (MDT) compounds for drug-resistant cancers ... sponsor- or investigator-initiated Investigational New Drug (IND) pathways. ...
Cached Medicine Technology:FDA Approves First Ceramic-on-Metal Total Hip Replacement System 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a ... years. He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ... 2014. , GoDaddy is a popular supplier of cheap ... hosting solutions at affordable rates. It offers three Linux ... plans depend on the length of the contract. The ...
(Date:8/22/2014)... Recently, Skmen.com, an experienced supplier of fashionable ... dresses in its online store. Moreover, all these excellent ... 28% off. All the international clients can obtain these ... , The company’s professional online workers update its ... customers more the latest information about its new arrivals ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) ... and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and ... Top 10 Best SEO Hosting states, “It is ... supplier. Actually, these companies have outperformed their competitors ... support. People can get the best web hosting ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 This ... (Instruments (Workstations, Liquid Handling Systems), Consumables (Tubes), Kits ... Users (Molecular Diagnostics) - Global Forecast to 2018" ... 2013 and is poised to grow at a ... reach $5,672.0 million by 2018. , Browse 98 ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Japantown Dental ... a new teeth whitening technique. Air polishing is a ... appointments. , Dark teeth can be caused by a ... external stains and internal stains. External stains include coffee, ... be caused by certain medications, such as tetracycline, and ...
Breaking Medicine News(10 mins):Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Japantown Dental Introduces Air Polishing 2
... likely to die after coronary artery bypass grafting (CABG) ... ,Other studies examining the link between depression and ... either because of small sample size or short follow-up. ... Centers in Durham, North Carolina, assessed the outcomes of ...
... imaging techniques -- the so-called CT and PET scans -- ... study.// ,Italian researchers from the National Cancer Institute in ... (or positron emission tomography) scans in their study of more ... minimum of 26 cigarettes a day for 37 years. ...
... head and neck cancers that’s aimed at boosting the ... and neck cancers have suppressed immune systems, and these ... development of the cancerous tumors. Research also exists suggesting ... in treating various forms of cancer by boosting immune ...
... In one of the first studies of its kind, ... on health. The study, led by doctors at the ... impacts the left side of the brain and has ... in a work environment with healthy employees. During an ...
... than other people, scientists said on Friday. Researchers in Denmark ... who died between 1943 and 1993 and compared their rates ... suicide rate was lower for twins, regardless of their sex.// ... have suggested that twins are slightly more prone to mental ...
... patients less likely to have a heart attack, U.S. ... inhibitors (SSRIs), such as sertraline (Zoloft), make the blood ... ,The study, published in the American Heart Association ... //should check heart patients for depression and treat it ...
Cached Medicine News:
The ABL77 is always ready to use. No manual cassette preparation or calibration necessary prior to testing. Portable with battery. For both high and low volume testing....
... importance of electronic connectivity for ... understood. Transmission of patient results ... records, and billing. A sound ... connectivity is essential to ensure ...
348 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
Medicine Products: